StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) KPIs and segments

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.82−0.00 (-0.49%)

Close on Nov 16, 2026Market cap $8.04MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive IN8bio's business

Coming soon

This tab will track the numbers specific to IN8bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?